 Xiaomin Zhang
Concepts (126)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serum Response Factor | 8 | 2024 | 43 | 2.060 |
Why?
| | Myocardium | 8 | 2021 | 453 | 1.340 |
Why?
| | Transcription Factors | 7 | 2024 | 566 | 1.270 |
Why?
| | Aging | 5 | 2016 | 701 | 1.150 |
Why?
| | MicroRNAs | 3 | 2015 | 387 | 0.910 |
Why?
| | Sirtuins | 1 | 2021 | 11 | 0.710 |
Why?
| | Gene Expression Regulation | 7 | 2016 | 990 | 0.650 |
Why?
| | Genetic Variation | 1 | 2021 | 230 | 0.640 |
Why?
| | Heart | 2 | 2015 | 345 | 0.570 |
Why?
| | Sirtuin 2 | 1 | 2017 | 11 | 0.570 |
Why?
| | RNA, Messenger | 5 | 2021 | 1132 | 0.530 |
Why?
| | Mitochondria, Heart | 1 | 2016 | 37 | 0.510 |
Why?
| | Histones | 2 | 2022 | 314 | 0.480 |
Why?
| | Mice | 11 | 2024 | 5949 | 0.470 |
Why?
| | Alternative Splicing | 2 | 2021 | 62 | 0.440 |
Why?
| | Animals | 12 | 2024 | 13505 | 0.390 |
Why?
| | Lipopolysaccharides | 2 | 2024 | 206 | 0.380 |
Why?
| | Cardiomegaly | 1 | 2011 | 38 | 0.350 |
Why?
| | Amino Acid Sequence | 5 | 2011 | 578 | 0.320 |
Why?
| | Mitochondria | 6 | 2024 | 430 | 0.320 |
Why?
| | Heart Failure | 1 | 2015 | 565 | 0.310 |
Why?
| | NADH Dehydrogenase | 1 | 2008 | 7 | 0.290 |
Why?
| | Electron Transport Complex I | 1 | 2008 | 21 | 0.290 |
Why?
| | Promoter Regions, Genetic | 4 | 2017 | 467 | 0.280 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1105 | 0.270 |
Why?
| | Porphyromonas gingivalis | 2 | 2024 | 17 | 0.270 |
Why?
| | Trans-Activators | 3 | 2016 | 135 | 0.250 |
Why?
| | Actins | 2 | 2022 | 115 | 0.250 |
Why?
| | Nuclear Proteins | 3 | 2016 | 245 | 0.240 |
Why?
| | Protein Isoforms | 2 | 2021 | 123 | 0.240 |
Why?
| | Molecular Sequence Data | 4 | 2008 | 778 | 0.240 |
Why?
| | Valine | 1 | 2024 | 57 | 0.210 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2024 | 43 | 0.210 |
Why?
| | Proteins | 1 | 2006 | 348 | 0.210 |
Why?
| | Microglia | 1 | 2024 | 113 | 0.200 |
Why?
| | Base Sequence | 2 | 2017 | 640 | 0.190 |
Why?
| | NIH 3T3 Cells | 3 | 2008 | 51 | 0.190 |
Why?
| | Amino Acids, Essential | 1 | 2023 | 133 | 0.180 |
Why?
| | Proteomics | 1 | 2024 | 329 | 0.180 |
Why?
| | Humans | 14 | 2024 | 52483 | 0.180 |
Why?
| | Genetic Loci | 1 | 2021 | 49 | 0.180 |
Why?
| | Genome | 1 | 2021 | 62 | 0.170 |
Why?
| | Exons | 1 | 2021 | 102 | 0.170 |
Why?
| | Zinc | 1 | 2021 | 56 | 0.170 |
Why?
| | Protein Structure, Tertiary | 1 | 2021 | 242 | 0.170 |
Why?
| | Cell Line | 2 | 2024 | 1030 | 0.160 |
Why?
| | Oxidative Stress | 3 | 2024 | 807 | 0.160 |
Why?
| | Dietary Supplements | 1 | 2023 | 465 | 0.150 |
Why?
| | Conserved Sequence | 2 | 2011 | 53 | 0.150 |
Why?
| | Mice, Inbred C57BL | 2 | 2016 | 1884 | 0.150 |
Why?
| | Human Umbilical Vein Endothelial Cells | 2 | 2016 | 99 | 0.150 |
Why?
| | Blood | 1 | 2017 | 26 | 0.140 |
Why?
| | Culture Media | 1 | 2017 | 98 | 0.140 |
Why?
| | Signal Transduction | 3 | 2024 | 1671 | 0.140 |
Why?
| | Homeostasis | 1 | 2017 | 201 | 0.130 |
Why?
| | Tissue Distribution | 2 | 2008 | 171 | 0.130 |
Why?
| | Mice, Transgenic | 2 | 2011 | 552 | 0.130 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2015 | 11 | 0.120 |
Why?
| | Protein Kinases | 1 | 2015 | 72 | 0.120 |
Why?
| | Protein Binding | 2 | 2008 | 667 | 0.110 |
Why?
| | Oxygen Consumption | 1 | 2015 | 198 | 0.110 |
Why?
| | Metformin | 1 | 2015 | 76 | 0.110 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 211 | 0.100 |
Why?
| | beta-Galactosidase | 1 | 2013 | 33 | 0.100 |
Why?
| | Rats | 2 | 2011 | 3220 | 0.100 |
Why?
| | Models, Biological | 2 | 2008 | 735 | 0.100 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2013 | 78 | 0.100 |
Why?
| | Blood Glucose | 1 | 2015 | 473 | 0.100 |
Why?
| | Cells, Cultured | 3 | 2015 | 1567 | 0.100 |
Why?
| | Eukaryotic Initiation Factors | 1 | 2012 | 5 | 0.100 |
Why?
| | Argonaute Proteins | 1 | 2012 | 12 | 0.100 |
Why?
| | Multigene Family | 1 | 2012 | 48 | 0.100 |
Why?
| | Nitric Oxide | 1 | 2013 | 249 | 0.090 |
Why?
| | Glucose | 1 | 2013 | 355 | 0.090 |
Why?
| | Transcription, Genetic | 1 | 2012 | 378 | 0.090 |
Why?
| | Down-Regulation | 1 | 2011 | 346 | 0.080 |
Why?
| | Up-Regulation | 1 | 2011 | 454 | 0.080 |
Why?
| | NAD | 1 | 2008 | 45 | 0.070 |
Why?
| | Protein Subunits | 1 | 2008 | 79 | 0.070 |
Why?
| | Serum Response Element | 1 | 2007 | 4 | 0.070 |
Why?
| | Codon, Nonsense | 1 | 2007 | 28 | 0.070 |
Why?
| | HeLa Cells | 1 | 2008 | 265 | 0.070 |
Why?
| | Models, Genetic | 1 | 2007 | 169 | 0.070 |
Why?
| | Animals, Newborn | 1 | 2008 | 362 | 0.070 |
Why?
| | Myocytes, Cardiac | 1 | 2008 | 129 | 0.070 |
Why?
| | Zinc Fingers | 1 | 2006 | 23 | 0.060 |
Why?
| | Sequence Alignment | 1 | 2006 | 125 | 0.060 |
Why?
| | Organ Specificity | 1 | 2006 | 115 | 0.060 |
Why?
| | Binding Sites | 1 | 2006 | 377 | 0.060 |
Why?
| | Two-Hybrid System Techniques | 1 | 2004 | 23 | 0.060 |
Why?
| | Atrial Natriuretic Factor | 1 | 2004 | 25 | 0.060 |
Why?
| | Blotting, Northern | 1 | 2004 | 106 | 0.060 |
Why?
| | Immunoprecipitation | 1 | 2004 | 57 | 0.060 |
Why?
| | DNA, Complementary | 1 | 2004 | 135 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2004 | 140 | 0.060 |
Why?
| | Transcriptional Activation | 1 | 2004 | 122 | 0.060 |
Why?
| | Plasmids | 1 | 2004 | 163 | 0.060 |
Why?
| | Homeodomain Proteins | 1 | 2004 | 80 | 0.060 |
Why?
| | Isoleucine | 1 | 2024 | 26 | 0.050 |
Why?
| | Glutathione Transferase | 1 | 2004 | 174 | 0.050 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 160 | 0.050 |
Why?
| | Cardiomyopathies | 1 | 2004 | 121 | 0.050 |
Why?
| | Leucine | 1 | 2024 | 114 | 0.050 |
Why?
| | Blotting, Western | 1 | 2004 | 590 | 0.050 |
Why?
| | Echocardiography, Doppler | 1 | 2003 | 57 | 0.050 |
Why?
| | Ternary Complex Factors | 1 | 2022 | 4 | 0.050 |
Why?
| | Models, Animal | 1 | 2003 | 234 | 0.050 |
Why?
| | Anilides | 1 | 2022 | 19 | 0.050 |
Why?
| | Blood Proteins | 1 | 2023 | 85 | 0.050 |
Why?
| | Benzamides | 1 | 2022 | 50 | 0.050 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2003 | 108 | 0.050 |
Why?
| | Eating | 1 | 2023 | 159 | 0.050 |
Why?
| | Lysine | 1 | 2022 | 89 | 0.050 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 205 | 0.050 |
Why?
| | Adult | 3 | 2023 | 14161 | 0.050 |
Why?
| | Gene Expression | 1 | 2003 | 618 | 0.040 |
Why?
| | Cytokines | 1 | 2024 | 623 | 0.040 |
Why?
| | Aged | 2 | 2023 | 10121 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2024 | 332 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 1470 | 0.040 |
Why?
| | Time Factors | 1 | 2004 | 2968 | 0.040 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2015 | 31 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 270 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 177 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 1378 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 1023 | 0.020 |
Why?
|
|
Zhang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|